Skip to main content

Table 2 Prevalence of diabetes, diabetes clinic visits, HbA1c testing and HbA1c over 9% by SEP and age, 2018

From: Trends and socioeconomic disparities in diabetes prevalence and quality of care among Israeli children; 2011-2018

  Total SEP 1 SEP 2 SEP 3 SEP 4 OR* (linear trend) P-value (trend)
% % % %
Diabetes Prevalence
Age groups
  2–9 0.05 0.04 0.05 0.04 0.06 1.05 0.198
  10–14 0.18 0.17 0.18 0.18 0.18 1.02 0.409
  15–17 0.28 0.24 0.30 0.29 0.32 1.04 0.004
Total (n = 2,267,785) 0.13 0.12 0.13 0.12 0.14 1.04 0.045
Diabetes clinic visits
Age groups
  2–9 90.89 91.10 89.27 91.19 92.16 1.06 0.674
  10–14 86.48 83.48 87.39 87.47 90.67 1.21 0.023
  15–17 84.86 78.23 84.26 85.71 94.48 1.47 < 0.001
Total (n = 3019) 86.78 83.07 86.59 87.56 92.36 1.28 < 0.001
HbA1c testing
Age groups
  2–9 71.06 80.82 70.06 65.41 60.78 0.73 < 0.001
  10–14 77.20 81.08 81.09 72.70 67.88 0.77 < 0.001
  15–17 81.26 85.61 83.02 79.59 72.39 0.77 < 0.001
Total (n = 3019) 77.44 82.67 79.53 73.77 67.90 0.76 < 0.001
HbA1c over 9%
Age groups
  2–9 24.49 38.14 26.61 11.54 6.45 0.48 < 0.001
  10–14 38.94 53.33 40.99 26.05 19.08 0.57 < 0.001
  15–17 33.26 41.81 36.80 26.07 14.41 0.65 < 0.001
Total (n = 2338) 34.05 46.13 36.69 23.54 14.79 0.59 < 0.001
  1. *We used univariable logistic regression to assess whether the association between prevalence of diabetes, diabetes clinic visits, HbA1C testing and HbA1C over 9%, and SEP (as a continuous variable) displayed a linear trend. OR reflects a one-unit change in SEP. Results in bold indicate statistical significance at the 0.05 level